Ameet K Mishra
Overview
Explore the profile of Ameet K Mishra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
176
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mishra A, Schmidt T, Martell E, Chen A, Dogru R, Hematti P, et al.
Transplant Cell Ther
. 2023 Nov;
30(2):191-202.
PMID: 37967650
Chimeric antigen receptor T cell (CAR-T) therapy has shown rapid, frequent, and deep responses in patients with relapsed/refractory multiple myeloma (RRMM). However, relapse frequently occurs following CAR-T therapy, and the...
2.
Mishra A, Kemler I, Dingli D
Blood Cancer J
. 2021 Jan;
11(1):3.
PMID: 33414408
Chimeric antigen receptor T (CAR-T) cell therapy is a transformative approach to cancer eradication. CAR-T is expensive partly due to the restricted use of each CAR construct for specific tumors....
3.
Mishra A, Dingli D
Leukemia
. 2019 Apr;
33(11):2695-2709.
PMID: 30988378
IL-6 signaling plays a crucial role in the pathogenesis of a number of diseases, including multiple myeloma, primary amyloidosis, cytokine release syndrome and other inflammatory conditions. It is central for...
4.
Wang X, Chen Z, Mishra A, Silva A, Ren W, Pan Z, et al.
Haematologica
. 2017 Dec;
103(3):466-476.
PMID: 29217775
Chemotherapeutic agents, e.g., cytarabine and doxorubicin, cause DNA damage. However, it remains unknown whether such agents differentially regulate cell cycle arrest in distinct types of B-cell lymphomas, and whether this...
5.
Mishra A, Parish C, Wong M, Licinio J, Blackburn A
PLoS One
. 2017 May;
12(5):e0178454.
PMID: 28542577
Epidemiological studies have shown obesity to be linked with poorer outcomes in breast cancer patients. The molecular mechanisms responsible for the increased risk of invasive/metastatic disease with obesity are complex,...
6.
Mishra A, Kadoishi T, Wang X, Driver E, Chen Z, Wang X, et al.
Oncotarget
. 2016 Nov;
7(49):81341-81356.
PMID: 27835902
Squamous cell carcinoma (SCC) is the second commonest type of skin cancer. Moreover, about 90% of head and neck cancers are SCCs. SCCs develop at a significantly higher rate under...
7.
Chen Z, Gowan K, Leach S, Viboolsittiseri S, Mishra A, Kadoishi T, et al.
BMC Genomics
. 2016 Oct;
17(1):823.
PMID: 27769169
Background: Whole genome next generation sequencing (NGS) is increasingly employed to detect genomic rearrangements in cancer genomes, especially in lymphoid malignancies. We recently established a unique mouse model by specifically...
8.
Mishra A, Abrahamsson A, Dabrosin C
Oncotarget
. 2016 Aug;
7(35):56876-56888.
PMID: 27486755
The estrogen receptor-alpha (ERα) is used as a predictive marker for anti-estrogen therapy in breast cancer patients. In addition to aromatase inhibitors, ERα can be targeted at the receptor level...